Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CART-PSMA cells in advanced prostate cancer
NCT05656573Phase 1Recruiting
- Sponsor
- Nova Therapeutics
- Start
- Mar 2023
- Primary completion
- Dec 2025
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
Phase 1, open-label trial of CART-PSMA cells in prostate cancer (PCa) (4 arms), sponsored by Nova Therapeutics. Primary endpoint: Occurrence of study related adverse events up to 15 years. Started Mar 2023; status: recruiting.
02
Drugs
CART-PSMA cells
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05656573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05656573.